Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Gold rises 0.6 % after hitting 14 month low today

    November 20, 2026

    Climate Council warns data centres could rival coal plants

    November 19, 2026

    Tinned food and grab bags urged as extreme weather looms

    November 18, 2026
    Adelaide ObserverAdelaide Observer
    • Automotive

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      Nissan unveils next-gen urban self-driving tech in Tokyo trial

      September 22, 2025

      Cadillac’s new EV concept targets rugged terrain

      August 15, 2025

      EV incentives end as automakers pivot to gas vehicles

      August 13, 2025

      Dodge SRT Hellcat returns as most powerful gas SUV at 710 horsepower

      August 11, 2025
    • Business

      Gold rises 0.6 % after hitting 14 month low today

      November 20, 2026

      Gold steadies after 3% slide on hot US inflation data

      November 12, 2026

      OpenAI raises $11 billion at $1.25 trillion valuation

      November 9, 2026

      IEA maps path to 25% cut in buildings energy intensity

      November 6, 2026

      CBA tips record 14% home price fall as Brisbane slides

      November 4, 2026
    • Entertainment

      Disney and Marvel’s R-rated film hits billion-dollar milestone

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024

      USHER’s pre-Super Bowl experience on Apple Music

      February 7, 2024

      Denzel Washington’s The Equalizer 3 strikes box office gold

      September 14, 2023

      Tom Cruise touches down in Abu Dhabi for Mission: Impossible premiere

      June 27, 2023
    • Health

      INTERPOL collaborates with WHO to combat health-related criminal activities

      October 17, 2026

      H5N1 Detected in Australian Mainland Long-Nosed Fur Seal, Confirming First Mammal Case

      August 24, 2026

      miR-342 Identification Offers New Strategy for Managing Triple-Negative Breast Cancer

      August 22, 2026

      Australian scientists create blood stem cells in lab

      May 2, 2026

      CSIRO-backed wheat lifts fibre in everyday white bread

      March 16, 2026
    • Lifestyle

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023

      How Nike’s Kobe 8 Protro Halo Marks an Emotional Milestone

      August 29, 2023

      From labels to legacy – understanding fashion’s hierarchy

      August 21, 2023
    • Luxury

      Price hikes and lack of innovation erode luxury market confidence

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      Tinned food and grab bags urged as extreme weather looms

      November 18, 2026

      NSW shelves underquoting rules hours before start date

      November 17, 2026

      AFP says 32 of 37 youth terror cases came in two years

      November 13, 2026

      Scanlon index holds at 78 as Australian pessimism rises

      November 5, 2026

      Australian Army Vehicle Rollover Results in Soldier’s Death and Five Injuries

      October 6, 2026
    • Sports

      USA tops Australia 2-0 in Seattle World Cup clash

      June 20, 2026

      Russian engineers launch AI robot for athletes’ training

      July 19, 2025

      Liverpool’s Salah earns top writers’ award for 2025

      May 9, 2025

      Manchester City secures Haaland with unprecedented nine-year contract

      January 18, 2025

      Lewis Hamilton bids farewell to Mercedes after 245 races

      December 6, 2024
    • Technology

      Climate Council warns data centres could rival coal plants

      November 19, 2026

      OECD finds AI gaps persist between firms and generations

      November 6, 2026

      iPhone Duo sets foldable benchmark with passport-style design

      November 2, 2026

      Apple iPhone Duo review: strong foldable with real trade-offs

      November 2, 2026

      Apple unveils MacBook Pro with OLED display and touch

      October 29, 2026
    • Travel

      Etihad Airways Significantly Increases Flight Frequency Between Abu Dhabi and Sydney

      September 29, 2026

      NRL Sets Auckland 2027 State of Origin Game Two Date for First-Ever International Match

      August 20, 2026

      Victoria sets entry fee and bookings for Twelve Apostles

      March 10, 2026

      Australia air traffic disrupted by major outage

      December 1, 2025

      Global aviation traffic expands in August despite headwinds

      October 1, 2025
    Adelaide ObserverAdelaide Observer
    Home » FDA grants approval to Cobenfy for schizophrenia management
    Health

    FDA grants approval to Cobenfy for schizophrenia management

    September 29, 2024
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    MENA Newswire News Desk: The U.S. Food and Drug Administration (FDA) has approved Cobenfy, a new medication for the treatment of schizophrenia, marking the first major advance in this area in more than three decades. Cobenfy, developed by Bristol Myers Squibb, is a twice-daily oral medication that combines two drugs, xanomeline and trospium chloride, offering a new therapeutic option for managing schizophrenia symptoms like hallucinations, delusions, and disorganized thinking.

    FDA grants approval to Cobenfy for schizophrenia management

    The FDA’s approval of Cobenfy offers fresh hope for millions of people living with schizophrenia, a severe mental health disorder that affects approximately 24 million people globally. According to Dr. Tiffany Farchione, Director of the Division of Psychiatry at the FDA’s Center for Drug Evaluation and Research, the approval breaks new ground in the treatment of this condition. “This is the first new approach to treating schizophrenia in decades, offering a valuable alternative to the antipsychotic medications that have been standard for so long,” she said.

    Most existing schizophrenia treatments focus on altering dopamine levels in the brain, a neurotransmitter linked to mood and behavior. Cobenfy, however, targets acetylcholine receptors, a different pathway in the brain that influences memory, learning, and attention. This novel mechanism of action is particularly important for patients who experience side effects such as weight gain, drowsiness, or movement disorders from traditional antipsychotics.

    In clinical trials, Cobenfy demonstrated significant effectiveness in reducing schizophrenia symptoms, with only 6% of patients discontinuing the drug due to side effects, compared to 20-30% with older medications. Dr. Samit Hirawat, Chief Medical Officer at Bristol Myers Squibb, hailed the results as a major improvement over previous treatment options.

    Common side effects of Cobenfy include nausea, constipation, and increased heart rate, according to the FDA’s approval notice. However, these side effects were notably less severe than those caused by earlier medications. Dr. Leslie Citrome, a professor of psychiatry at New York Medical College, emphasized that the drug could benefit patients who cannot tolerate the side effects of current treatments.

    Schizophrenia is a lifelong mental illness that typically begins in late adolescence or early adulthood and is characterized by distorted thinking, behavior, and emotions. It often leads to significant challenges in daily functioning, impacting work and relationships. The approval of Cobenfy could represent a breakthrough for patients who have struggled with available treatments for years. Cobenfy is expected to be available for prescription by the end of October, according to Adam Lenkowsky, Executive Vice President at Bristol Myers Squibb. Ongoing studies are also exploring its potential for treating other conditions, including Alzheimer’s disease and bipolar disorder.

    Related Posts

    Gold rises 0.6 % after hitting 14 month low today

    November 20, 2026

    INTERPOL collaborates with WHO to combat health-related criminal activities

    October 17, 2026

    Bird flu first endangered Australian sea lion dies at Seal Bay

    September 14, 2026

    H5N1 Detected in Australian Mainland Long-Nosed Fur Seal, Confirming First Mammal Case

    August 24, 2026

    miR-342 Identification Offers New Strategy for Managing Triple-Negative Breast Cancer

    August 22, 2026

    Australia updates National Disability Insurance Scheme standards

    August 1, 2026
    Latest News

    Gold rises 0.6 % after hitting 14 month low today

    November 20, 2026

    Climate Council warns data centres could rival coal plants

    November 19, 2026

    Tinned food and grab bags urged as extreme weather looms

    November 18, 2026

    NSW shelves underquoting rules hours before start date

    November 17, 2026

    AFP says 32 of 37 youth terror cases came in two years

    November 13, 2026

    Gold steadies after 3% slide on hot US inflation data

    November 12, 2026

    OpenAI raises $11 billion at $1.25 trillion valuation

    November 9, 2026

    OECD finds AI gaps persist between firms and generations

    November 6, 2026
    Business

    Gold rises 0.6 % after hitting 14 month low today

    November 20, 2026

    Gold steadies after 3% slide on hot US inflation data

    November 12, 2026

    OpenAI raises $11 billion at $1.25 trillion valuation

    November 9, 2026

    IEA maps path to 25% cut in buildings energy intensity

    November 6, 2026
    News

    Tinned food and grab bags urged as extreme weather looms

    November 18, 2026

    NSW shelves underquoting rules hours before start date

    November 17, 2026

    AFP says 32 of 37 youth terror cases came in two years

    November 13, 2026

    Scanlon index holds at 78 as Australian pessimism rises

    November 5, 2026
    Health

    INTERPOL collaborates with WHO to combat health-related criminal activities

    October 17, 2026

    H5N1 Detected in Australian Mainland Long-Nosed Fur Seal, Confirming First Mammal Case

    August 24, 2026

    miR-342 Identification Offers New Strategy for Managing Triple-Negative Breast Cancer

    August 22, 2026

    Australian scientists create blood stem cells in lab

    May 2, 2026
    © 2026 Adelaide Observer | All Rights Reserved
    • Home
    • Contact Us
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.